Dengue
Dengue is a viral infection spread to people by the bite of infected Aedes mosquitoes, especially Aedes aegypti and also Aedes albopictus. It is common in tropical and subtropical places, especially towns and cities. Many infections cause no symptoms or only a short flu-like illness, but some people become seriously ill with bleeding, shock, or organ problems. WHO says symptoms usually start 4 to 10 days after infection and most people recover in 1 to 2 weeks, while severe dengue can be fatal if care is delayed. There is no specific antiviral treatment. Care is mainly fluids, monitoring, and safe pain relief; aspirin and ibuprofen should be avoided because they can increase bleeding risk. A dengue vaccine exists, but WHO describes limits on who should receive dengue vaccines, so vaccination is not a simple universal solution. Dengue is spreading to new places, and WHO reported record global case numbers in 2024 and continued transmission in 2025.
Key facts
| Transmission | Bite of infected female Aedes mosquitoes, mainly Aedes aegypti and secondarily Aedes albopictus; WHO also notes uncommon mother-to-child transmission around birth and rare transmission through blood products, organ donation, or transfusion. |
|---|---|
| Incubation | Usually 4 to 10 days after infection, according to WHO; symptoms can begin within a broader 3 to 14 day range in the overview source. |
| Case fatality | Unknown as a single fixed figure. WHO states severe dengue can be fatal, and early detection and proper medical care greatly lower fatality rates. Reported outbreak CFRs vary by setting and year, for example 0.47% in Bangladesh in 2023 and 0.44% in Bangladesh in 2022. |
| Reproduction number | unknown |
| Vaccine | A vaccine exists, but WHO says dengue vaccine use has important eligibility limits and dengue prevention still relies heavily on mosquito control. |
| Treatment | No specific antiviral treatment. Treatment is supportive: pain control with paracetamol/acetaminophen, fluids, monitoring, and hospital care for severe dengue. Ibuprofen and aspirin should be avoided because of bleeding risk. |
| Reservoir | Humans are the main host in the urban transmission cycle described by WHO; the disease is maintained through mosquito-to-human transmission. |
| Endemic regions | Tropical and subtropical regions worldwide, mostly urban and semi-urban areas; WHO says dengue is endemic in more than 100 countries. |
Transmission
Dengue spreads mainly through the bite of infected female Aedes mosquitoes. WHO names Aedes aegypti as the main vector and Aedes albopictus as a secondary one. These mosquitoes often live around homes and bite during the day, so bed nets used only at night are not enough on their own. The WHO fact sheet says dengue is found mostly in urban and semi-urban settings, where water-holding containers can help mosquitoes breed. WHO also notes a few less common routes. A pregnant person can pass dengue to a baby around the time of birth, and rare transmission has been reported through blood products, transfusion, or organ donation. Dengue is not mainly spread by ordinary casual contact between people. The key step is an infected mosquito biting a person. That means local risk depends on both infected travelers or residents and the presence of competent Aedes mosquitoes.
- Dengue WHO
- Dengue fever Wikipedia
Symptoms and severity
Many dengue infections cause no symptoms, or only a mild illness. When symptoms do happen, WHO says they usually start 4 to 10 days after infection and last 2 to 7 days. Common symptoms are high fever, severe headache, pain behind the eyes, muscle and joint pain, nausea, vomiting, swollen glands, and rash. Most people recover in 1 to 2 weeks. A smaller group develop severe dengue, often around the time the fever is settling. Warning signs include severe abdominal pain, persistent vomiting, rapid breathing, bleeding from the gums or nose, blood in vomit or stool, marked tiredness, restlessness, thirst, pale or cold skin, and weakness. Severe dengue can lead to shock, major bleeding, or organ problems and may be fatal without prompt care. WHO also says a second dengue infection raises the risk of severe disease, because immunity to one serotype does not give lasting protection against the others.
- Dengue WHO
- Dengue- Global situation WHO · 21 Dec 2023
- Dengue fever Wikipedia
Treatment and vaccines
There is no specific antiviral treatment for dengue in the WHO fact sheet. Care is mainly supportive. For mild illness, WHO recommends pain relief with paracetamol, also called acetaminophen, along with rest and fluids. Ibuprofen and aspirin should be avoided because they can increase the risk of bleeding. People with warning signs or severe dengue often need hospital care for close monitoring and treatment of dehydration, bleeding, or shock. WHO says early detection and access to proper medical care greatly lower fatality rates of severe dengue. Vaccines do exist, but they are not a simple answer for everyone. WHO says vaccine use has eligibility limits and prevention still relies heavily on mosquito control and bite avoidance. In practice, treatment and prevention are still centered on supportive medical care, reducing mosquito breeding sites, and protecting people from bites during the day, especially during outbreaks.
- Dengue WHO
Where it occurs
Dengue occurs across tropical and subtropical parts of the world, mostly in urban and semi-urban areas. WHO says the disease is now endemic in more than 100 countries, and about half of the world’s population is at risk. The burden has risen sharply in recent decades. In 2024, WHO reported more dengue cases than in any previous 12-month period, with major impact in the Americas. WHO also says dengue is spreading into new areas, including parts of Europe and the Eastern Mediterranean region. The outbreak notice for Iran is important because it reported the first locally acquired dengue cases ever documented in that country in 2024. WHO’s global situation notices also highlight that non-endemic countries are increasingly affected when infected travelers arrive in places where Aedes mosquitoes are already present. So dengue is not only a disease of long-established hotspots; it is also a disease of expanding geographic risk where climate, travel, urban growth, and mosquito range overlap.
- Dengue WHO
- Dengue – Iran (Islamic Republic of) WHO · 22 Jul 2024
- Dengue - Global situation WHO · 30 May 2024
- Dengue- Global situation WHO · 21 Dec 2023
Recent history
On this site’s archive, dengue has 48 recorded major events since 1996, which shows repeated international concern rather than a one-off episode. Recent WHO notices describe a period of unusually high activity. In 2023, WHO reported large outbreaks in the Americas, Bangladesh, and Chad, and warned about geographical expansion beyond historical transmission areas. In the 2024 global situation notice, WHO said more than 7.6 million cases and over 3000 deaths had already been reported by 2024-04-30, with 90 countries showing active transmission that year. WHO’s Iran notice from 2024-07-22 documented the first locally acquired cases ever recorded in Iran. The WHO fact sheet later reported that 2024 became a record year, with over 14.6 million cases and more than 12 000 reported dengue-related deaths worldwide, and that from 2025-01 to 2025-07 over 4 million cases and over 3000 deaths were still being reported. The pattern is repeated outbreaks, wider spread, and pressure on health systems.
- Dengue – the Region of the Americas WHO · 19 Jul 2023
- Dengue - Bangladesh WHO · 11 Aug 2023
- Dengue - Chad WHO · 16 Oct 2023
- Geographical expansion of cases of dengue and chikungunya beyond the historical areas of transmission in the Region of the Americas WHO · 23 Mar 2023
What to watch
The main signs that dengue is becoming more concerning are geographic spread, heavier outbreaks, and strain on care. One signal is new local transmission in places that previously had only imported cases, as seen in Iran in 2024. Another is spread in regions where Aedes mosquitoes are present but dengue has not been well established, including parts of Europe and the Eastern Mediterranean. A second warning sign is a sharp rise in severe cases, deaths, or case fatality within an outbreak, which can mean delayed diagnosis or overwhelmed hospitals. WHO also points to factors that can amplify risk: high rainfall, heat, humidity, population movement, weak surveillance, and fragile health systems. Because there is no specific antiviral treatment, supportive care capacity matters. Vaccine supply and eligibility are also worth watching: if demand rises during large outbreaks, access may be uneven. In short, watch for new regions, more severe disease, stressed hospitals, and any evidence that prevention tools are not keeping up.
- Dengue WHO
- Dengue – Iran (Islamic Republic of) WHO · 22 Jul 2024
- Dengue - Global situation WHO · 30 May 2024
- Dengue- Global situation WHO · 21 Dec 2023
Related outbreaks
- Dengue Attention: elevated
- Dengue in France moderate